A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical ® in Healthy Volunteers
Condition: Overweight or Obesity Interventions: Drug: Xenical® vs EMP 22; Drug: EMP 22 vs Xenical®; Drug: EMP 16 vs Xenical® Sponsors: Empros Pharma AB; CTC Clinical Trial Consultants AB Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
Condition: Type 1 Hyperlipoprotenemia Interventions: Drug: Orlistat; Drug: Placebo Sponsor: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials